Literature DB >> 12222560

Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide.

Rita M Cool1, Jon D Herrington, Lucas Wong.   

Abstract

A 64-year-old woman receiving intravenous chemotherapy for stage IIIB non-small cell lung cancer experienced acute arterial thrombosis of the distal radial and entire ulnar arteries with subsequent arterial occlusion of the right popliteal artery. Two separate arterial occlusions occurred after administration of cisplatin and etoposide chemotherapy; the second occlusion occurred after rechallenge with the second cycle of chemotherapy. Although venous thrombosis is more common in patients with cancer than in the general population, chemotherapy-induced arterial thrombosis rarely has been reported. To our knowledge, peripheral arterial occlusion after the first and second cycles of platinum-based chemotherapy has not been reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12222560     DOI: 10.1592/phco.22.13.1200.33524

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  9 in total

1.  Reversible branch retinal artery occlusion following intravenous cisplatin chemotherapy for cervical carcinoma.

Authors:  Arijit Mitra; Matthew R Edmunds; Nawaz Walji; Indrajit N Fernando; Robert A H Scott; Peter Good
Journal:  Int Ophthalmol       Date:  2011-11-23       Impact factor: 2.031

2.  Aortic thrombosis resolved with enoxaparin in a patient treated with cisplatin-based regimen for small cell lung cancer.

Authors:  Sang Ouk Chin; Jae Jin Lee; Yeon Hee Hwang; Jae Joon Han; Chi Hoong Maeng; Sun Kyung Baek; Cheong Woong Choi
Journal:  Int J Hematol       Date:  2010-04-29       Impact factor: 2.490

3.  Capecitabine (oral 5-fluorouracil pro-drug) treatment for colorectal carcinoma causing ischaemic chest pain.

Authors:  Trevor Aidan McGoldrick; Duncan Jodrell; Sally Clive
Journal:  BMJ Case Rep       Date:  2009-02-26

Review 4.  Anti-angiogenesis or pro-angiogenesis for cancer treatment: focus on drug distribution.

Authors:  Dongsheng Huang; Huanrong Lan; Fanlong Liu; Shibing Wang; Xiaoyi Chen; Ketao Jin; Xiaozhou Mou
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 5.  Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond.

Authors:  Rohit Moudgil; Edward T H Yeh
Journal:  Can J Cardiol       Date:  2016-02-02       Impact factor: 5.223

6.  Acute Arterial Thrombosis during Postoperative Adjuvant Cisplatin-based Chemotherapy for Completely Resected Lung Adenocarcinoma.

Authors:  Chihiro Sato; Kenichi Okuda; Hiroyuki Tamiya; Kota Yamamoto; Katsuyuki Hoshina; Osamu Narumoto; Hirokazu Urushiyama; Satoshi Noguchi; Yosuke Amano; Kosuke Watanabe; Akihisa Mitani; Hidenori Kage; Goh Tanaka; Yasuhiro Yamauchi; Daiya Takai; Takahide Nagase
Journal:  Intern Med       Date:  2017-12-08       Impact factor: 1.271

7.  Developing a Reliable Mouse Model for Cancer Therapy-Induced Cardiovascular Toxicity in Cancer Patients and Survivors.

Authors:  Kyung Ae Ko; Yin Wang; Sivareddy Kotla; Yuka Fujii; Hang Thi Vu; Bhanu P Venkatesulu; Tamlyn N Thomas; Jan L Medina; Young Jin Gi; Megumi Hada; Jane Grande-Allen; Zarana S Patel; Sarah A Milgrom; Sunil Krishnan; Keigi Fujiwara; Jun-Ichi Abe
Journal:  Front Cardiovasc Med       Date:  2018-04-05

Review 8.  Cancer-Associated Thrombosis: A New Light on an Old Story.

Authors:  Sidrah Shah; Afroditi Karathanasi; Antonios Revythis; Evangelia Ioannidou; Stergios Boussios
Journal:  Diseases       Date:  2021-05-04

9.  Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future Management.

Authors:  Marwa S Hamza; Shaker A Mousa
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.